Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
23%
OVERLAP
BY WEIGHT
32
# OF OVERLAPPING
HOLDINGS
XBI
143
HOLDINGS
22%
ALSO IN CANC
CANC
54
HOLDINGS
59%
ALSO IN XBI
SECTOR DRIFT (XBI minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 1.8% | 3.7% | 1.8% |
|
AMGEN INC | 1.8% | 1.9% | 1.8% |
|
ABBVIE INC | 1.7% | 3.7% | 1.7% |
|
BRIDGEBIO PHARMA, INC. | 1.5% | 3.0% | 1.5% |
|
HALOZYME THERAPEUTICS INC | 1.4% | 3.1% | 1.4% |
XBI Overweight Relative to CANC
|
MODERNA, INC. | 2.8% |
|
SPYRE THERAPEUTICS INC | 1.8% |
|
BIOGEN IDEC INC | 1.8% |
|
ORUKA THERAPEUTICS INC | 1.7% |
|
REGENERON PHARMACEUTICALS | 1.7% |
|
UNITED THERAPEUTICS CORP | 1.6% |
|
TG THERAPEUTICS INC | 1.6% |
|
NEUROCRINE BIOSCIENCES INC | 1.6% |
|
VERTEX PHARMACEUTICALS INC | 1.6% |
 |
ALKERMES PLC | 1.5% |
XBI Underweight Relative to CANC
 |
GENMAB A/S SPONSORED ADR | -5.9% |
|
ELI LILLY & CO | -5.2% |
|
MERCK & CO. INC. | -4.9% |
|
REVOLUTION MEDICINES, INC. | -4.5% |
 |
NOVARTIS AG | -4.2% |
|
BEIGENE LTD. SPONSORED ADR | -4.1% |
|
COGENT BIOSCIENCES INC | -3.4% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -3.1% |
|
ENLIVEN THERAPEUTICS, INC. | -2.7% |
|
BRISTOL-MYERS SQUIBB CO | -2.7% |